Skip to main content

BioMerieux Acquires Microbial Genotyping Firm Bacterial Barcodes

NEW YORK (GenomeWeb News) — BioMerieux said today that it has acquired molecular biotechnology firm Bacterial Barcodes.

Bacterial Barcodes, based in Athens, Ga., has developed and markets DiversiLab, a system for automated microbial genotyping that can be used to track hospital-acquired infections, and for environmental control for product safety. 

Financial terms of the deal were not disclosed.

"The addition of [DiversiLab to] bioMerieux's technology portfolio is perfectly aligned with the company's strategic commitment to focus on infectious diseases, as well as on industrial applications,” Eric Bouvier, president and CEO of BioMerieux’s North American operations, said in a statement.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.